You get results: faster, sharper, and more aligned with what patients truly need. That was the driving force behind the 9th annual JKTG Symposium, held October 15, 2025 in Washington D.C. This year’s theme, "Improving Breast Cancer Outcomes: Revealing and Targeting Tumor–Immune Interactions," was more than a title. It was a call to action.

If a project is safe, it will get funded. If it’s bold, uncertain, or disruptive, it probably won’t. That’s the problem. High-risk cancer research is exactly where the biggest breakthroughs often happen. But in most traditional funding models, the riskiest projects get pushed aside, not because they’re wrong, but because they don’t fit the system. This is where philanthropy comes in. And this is why the JKTG Foundation exists...

We throw the word legacy around a lot. People use it to mean all kinds of things: a name on a building, a career full of accolades, a foundation that writes checks in your honor. But in my experience, real legacy isn’t about how things look. It’s about whether what you built keeps working when you’re no longer in the picture. In cancer research, that’s especially important. If your funding, your connections, or your ideas are holding everything together, then you’re not build

For years, I’ve funded cancer research behind the scenes. Now, we’re taking the conversation public, with the launch of Driving Research, the JKTG Foundation’s first-ever cancer research podcast. And we’re starting with a conversation that matters...

In racing, like in life, you’re constantly making decisions with incomplete information. That’s exactly what we faced this weekend at Mid-Ohio. The forecast was on a knife’s edge. Some said rain, some said it would hold off. The track was dry, but the skies weren’t exactly confident about staying that way. So we made a call. Two different ones, actually...